Board of Directors

The Board of Directors s the Company’s highest decision-making, supervision and control body, except in matters reserved to the General Shareholders’ Meeting.

Its composition is adapted to the recommendations of the CNMV’s Good Governance Code for Companies.

All the directors were appointed on the basis of their merits, irrespective of gender.

According to the Bylaws, the Board must be formed by no less than five and no more than fifteen members.

As the highest decision-making body, it delegates ordinary business management to the management team and concentrates its activities on general supervisory duties.

Therefore, the Board must direct its policies towards:

  • Supervising Management
  • Evaluating the perfomance of managers
  • Apodting the Company's most important decisions
  • Liasing with shareholders

Duties:

  • To strive to ensure the regulatory requirements and the Company’s social and ethical duties are met
  • To ensure that no one person or small group exercises decision-making power within the Company
  • To ensure that no shareholder is treated more favourably than others

Responsibilities:

  • Preparing the strategic plan
  • Fixing management objectives and the annual budget
  • Defining the structure of the company group
  • Establishing the investment and financing policy
  • Approving the dividend, corporate governance and social responsibility policies

All the responsibilities of the Board of Directors are set out in article 5 of the Regulations of the Board of Directors.

Directors

Mr Juan López-Belmonte López

Chairman and Chief Executive Manager

PositionDominical

First Appointment27 July, 2007

Latest Appointment13 June, 2012

 

Chairman of ROVI for the last 22 years, he graduated in Economic and Business Sciences from the Universidad Complutense de Madrid in 1969 and is an insurance actuary. In addition to Chairman of the Board of Directors of ROVI, he is also President of the Madrid Chamber of Commerce, a member of the Plenary Session of the Spanish Chamber of Commerce and a member of the governing body of the IFEMA (Madrid Trade Fair Institute). He is a shareholder of Norbel Inversiones, S.L. (ROVI’s controlling shareholder).

Other Boards of Directors on which he sits
Company Position / Partner
NORBEL INVERSIONES, S.L. Presidente
NORBEPA INVERSIONES, S.L. Presidente
LOBEL Y LOSA DEVELOPMENT, S.L. Presidente
INVERSIONES BORBOLLÓN, S.L. Presidente
ALENTIA BIOTECH, S.L. Presidente
Shares held in company

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr Juan López-Belmonte Encina

Board member and Chief Executive Manager

PositionExecutive

First Appointment27 July, 2007

Latest Appointment13 de June, 2012

 

Chief Executive Officer since October 2007, he has been working for the Company since 1994 and was appointed General Manager in 2001. He graduated in Economic and Business Sciences from CEU San Pablo, Madrid, specializing in Auditing, in 1993. He began his professional career working in important international pharmaceutical companies, such as Nielzen Group in Spain, Tyco Group in the United States, and Boots Pharmaceuticals in the United Kingdom, in different pharmaceutical areas. He is a member of the Board of Governors and Executive Board of Farmaindustria and a member of the Governing Board of the CEOE (Spanish Confederation of Business Organizations). He is a shareholder of Norbel Inversiones, S.L. (ROVI’s controlling shareholder).

Other Boards of Directors on which he sits
Company Position / Partner
NORBEL INVERSIONES, S.L. Presidente
NORBEPA INVERSIONES, S.L. Presidente
LOBEL Y LOSA DEVELOPMENT, S.L. Presidente
INVERSIONES BORBOLLÓN, S.L. Presidente
ALENTIA BIOTECH, S.L. Presidente
Shares held in company

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr Iván López-Belmonte Encina

1st Vicepresident

PositionExecutive

First Apponitment27 de July, 2007

Latest Appointment13 de June, 2012

 

Corporate Development Manager since 2007 and Assistant General Manager since 2001, he graduated in Economic and Business Sciences from Universidad Complutense de Madrid, specializing in Auditing, in 1994. He began his professional career in Germany, working in pharmaceutical sector companies such as Amersham and Hexal AG.  He has been working for the Company since 1994. He is a shareholder of Norbel Inversiones, S.L. (ROVI’s controlling shareholder).

Other Boards of Directors on which he sits
Company Position / Partner
NORBEL INVERSIONES, S.L. Presidente
NORBEPA INVERSIONES, S.L. Presidente
LOBEL Y LOSA DEVELOPMENT, S.L. Presidente
INVERSIONES BORBOLLÓN, S.L. Presidente
ALENTIA BIOTECH, S.L. Presidente
Shares held in company

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr Javier López-Belmonte Encina

2nd Vicepresident

PositionExecutive

First Appointment27 de July, 2007

Latest Appointment13 de June, 2012

 

Chief Financial Officer since 2001, he graduated in Economic and Business Sciences from Colegio Universitario de Estudios Financieros (CUNEF), Madrid, specializing in Financing, in 1998. He began his professional career in the banking sector in 1998, working for Argentaria, S.A. in the United Kingdom as an analyst and in the pharmaceutical sector with Medeva Pharma. He joined ROVI in 2000. He is Vice-president of the CEIM (Madrid Business Confederation) and a shareholder of Norbel Inversiones, S.L. (ROVI’s controlling shareholder).

Other Boards of Directors on which he sits
Company Position / Partner
NORBEL INVERSIONES, S.L. Presidente
NORBEPA INVERSIONES, S.L. Presidente
LOBEL Y LOSA DEVELOPMENT, S.L. Presidente
INVERSIONES BORBOLLÓN, S.L. Presidente
ALENTIA BIOTECH, S.L. Presidente
Shares held in company

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr Enrique Castellón Leal

Adviser and coordinator

PositionIndependent

First Appointment24 de October, 2007

Latest Appointment13 de June, 2012

 

Independent director. Founding shareholder and Chairman of the Board of Directors of CrossRoadBiotech SCR. He holds a degree in Medicine and Surgery from Universidad Complutense de Madrid and is a specialist in internal medicine. Likewise, he graduated in Economic and Business Sciences from Universidad Autónoma de Madrid and holds a Master’s degree in Health Policy and Management from the University of Harvard. He has been a physician with the Internal Medicine Service at Hospital Clínico San Carlos, Madrid, a Social Security Medical Inspector, General Manager of the Galician Health Service, Deputy Head of the Health Department of the Madrid Autonomous Region and Undersecretary at the Ministry of Health and Consumption. Likewise, he regularly advises several foundations engaged in health science research and carries on consulting activities with Castellón Abogados. He has worked as a consultant on health policy matters for the Inter-American Development Bank (World Bank Group).

Other Boards of Directors on which he sits
Company Position / Partner
NORBEL INVERSIONES, S.L. Presidente
NORBEPA INVERSIONES, S.L. Presidente
LOBEL Y LOSA DEVELOPMENT, S.L. Presidente
INVERSIONES BORBOLLÓN, S.L. Presidente
ALENTIA BIOTECH, S.L. Presidente
Shares held in company

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr Miguel Corsini Freese

Board member

PositionIndependent

First Appointment12 de November, 2008

Latest Appointment12 de June, 2014

 

Independent director. He is currently a member of the Executive Commission of the Confederación Empresarial de Madrid (CEIM) (Madrid Business Confederation) and a member of the Governing Board of the CEOE (Spanish Confederation of Business Organizations).

He holds a degree in Law and is an expert in Labour Law. His professional career was linked to Renfe for many years, chairing its Board of Directors from 1996 to 2004. In October 2007, he was appointed First Vice-president of the Madrid Chamber of Commerce. He sits on the Boards of Directors of several companies, such as Legalitas and Azvi, and is the President of Cetren.

Other Boards of Directors on which he sits
Company Position / Partner
NORBEL INVERSIONES, S.L. Presidente
NORBEPA INVERSIONES, S.L. Presidente
LOBEL Y LOSA DEVELOPMENT, S.L. Presidente
INVERSIONES BORBOLLÓN, S.L. Presidente
ALENTIA BIOTECH, S.L. Presidente
Shares held in company

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr José Fernando de Almansa Moreno-Barreda

Vocal

PositionIndependent

First Appointment09 de June, 2015

Latest Appointment09 de June, 2015

 

Independent director. He holds a Law degree from the University of Deusto (Bilbao) and is a diplomat. He joined the Diplomatic Service on 2 December, 1974 and, from 1976 to 1992, held a variety of positions: Secretary of the Spanish Embassy in Brussels, Cultural Attaché at the Spanish Embassy in Mexico, Chief Director of the Coordination Section of the Subdirectorate-General for Eastern Europe, Director of Atlantic Affairs at the Directorate-General of Foreign Policy for Europe and Atlantic Affairs, Political Counsellor to the Permanent Representative of Spain on the North Atlantic Council in Brussels, Minister-Counsellor of the Spanish Embassy in the Soviet Union, Secretary General of the National Commission for the V Centenary of the Discovery of American and Subdirector General for Eastern Europe, reporting to the Directorate-General of Foreign Policy for Europe. From 1993 to 2002, he held the position of Head of the King’s Household, with the rank of Minister, having been appointed by HRH. King Juan Carlos I, and was likewise appointed Privy Counsellor to HRH King Juan Carlos I.

Other Boards of Directors on which he sits
Company Position / Partner
NORBEL INVERSIONES, S.L. Presidente
NORBEPA INVERSIONES, S.L. Presidente
LOBEL Y LOSA DEVELOPMENT, S.L. Presidente
INVERSIONES BORBOLLÓN, S.L. Presidente
ALENTIA BIOTECH, S.L. Presidente
Shares held in company

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr Gabriel Nuñez Fernández

Non-director Secretary

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum

Other Boards of Directors on which he sits
Company Position / Partner
NORBEL INVERSIONES, S.L. Presidente
NORBEPA INVERSIONES, S.L. Presidente
LOBEL Y LOSA DEVELOPMENT, S.L. Presidente
INVERSIONES BORBOLLÓN, S.L. Presidente
ALENTIA BIOTECH, S.L. Presidente
Shares held in company

% of voting rights

% Direct
% Indirect
% Total

0
0
0